De Novo Atherosclerotic Renal Artery Stenosis Covered Stent Treatment for Resistant Hypertension (ARTISAN) Results
The high primary patency and improvement in SBP, persisting through 36 months, suggest that the iCast RX covered stent is safe and effective for the treatment of appropriately selected patients with ARAS.
Authors
- Ashit Jain
- Ravish Sachar
- Kenneth Rosenfield (ORCID: https://orcid.org/0000-0002-5633-6983)
- Douglas E. Drachman (ORCID: https://orcid.org/0000-0003-1538-5807)
- Amr E. Abbas (ORCID: https://orcid.org/0000-0002-7316-4247)
- Gary M. Ansel (ORCID: https://orcid.org/0000-0003-0612-4269)
- D. Christopher Metzger
Institutions
- Ohio Department of Health (US)
- Massachusetts General Hospital (US)
- Beaumont Hospital, Royal Oak (US)
- Ohio Heart & Vascular Center (US)
- Medical Research Associates (US)
- University of Toledo (US)
Publication Details
- Journal
- Journal of the Society for Cardiovascular Angiography & Interventions
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1016/j.jscai.2024.102400
- Citations
- 1
- Primary Topic
- Renal and Vascular Pathologies
- Type
- article
- Field-Weighted Citation Impact
- 0.42